Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to identify the epidemiological and clinical characteristics of patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019.


Clinical Trial Description

Vibrios are gram-negative, ubiquitous bacteria of the marine flora and are found particularly in warm waters. For example, the incidence is high in Florida and Vibrio infections are now reportable in the United States. Different species of Vibrio are described. A distinction is made between choleric vibrios belonging to serogroups O1 and O139, responsible for cholera epidemics, and non-choleric vibrios. Our study will focus on non-cholera vibrios. Vibrio infections can occur by eating contaminated raw seafood or by exposure of a wound to the marine environment. They occur mainly during the hot summer months. This can be explained on the one hand by higher water temperature and on the other hand by increased beach use. With global warming, it is possible that Vibrio infections may increase in number and location. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04451707
Study type Observational
Source Groupe Hospitalier de la Rochelle Ré Aunis
Contact
Status Completed
Phase
Start date March 12, 2020
Completion date June 17, 2020

See also
  Status Clinical Trial Phase
Terminated NCT00624975 - Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants Phase 2
Completed NCT00419133 - Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine Phase 2
Completed NCT00741637 - Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults Phase 2
Completed NCT00289224 - Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata Phase 3
Not yet recruiting NCT00548054 - Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants Phase 2